Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves prostate cancer detection in PSA test.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Finasteride reduces prostate size and PSA levels in young patients.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

Some common medications can lower PSA levels in 45-year-old German men.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Finasteride treatment makes the prostate look more like a healthy one.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Urinary PSA could be an early marker for enlarged prostate.